Recent News

• 03.18.2026 - Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026
• 03.16.2026 - Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
• 03.04.2026 - Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute
• 02.20.2026 - Fennec Pharmaceuticals Presents Real World Data Supporting the Integration and Clinical Use of PEDMARK® in Treating Adults with Head & Neck Cancers

Recent Filings

• 03.16.2026 - 8-K Current report
• 03.16.2026 - EX-99.1 EX-99.1
• 03.05.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 03.04.2026 - EX-99.1 EX-99.1
• 03.04.2026 - 8-K Current report
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.02.2026 - 144 Report of proposed sale of securities
• 02.20.2026 - EX-99.1 EX-99.1
• 02.20.2026 - 8-K Current report